Quotient Wealth Partners LLC Acquires 1,224 Shares of Zoetis Inc. $ZTS

Quotient Wealth Partners LLC raised its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 38.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 4,391 shares of the company’s stock after acquiring an additional 1,224 shares during the period. Quotient Wealth Partners LLC’s holdings in Zoetis were worth $685,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in ZTS. Nuveen LLC acquired a new position in Zoetis in the first quarter valued at about $616,375,000. Mackenzie Financial Corp raised its position in shares of Zoetis by 4,158.3% in the 1st quarter. Mackenzie Financial Corp now owns 1,824,967 shares of the company’s stock valued at $300,481,000 after acquiring an additional 1,782,110 shares during the period. Polen Capital Management LLC raised its position in shares of Zoetis by 17.6% in the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock valued at $1,448,401,000 after acquiring an additional 1,313,653 shares during the period. Amundi boosted its stake in Zoetis by 30.8% during the 1st quarter. Amundi now owns 3,595,628 shares of the company’s stock worth $575,691,000 after acquiring an additional 846,909 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd boosted its position in shares of Zoetis by 475.9% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 900,261 shares of the company’s stock worth $148,228,000 after purchasing an additional 743,926 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and cut their price target for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Argus reaffirmed a “buy” rating and set a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Finally, Piper Sandler boosted their target price on Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Four research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $196.71.

Zoetis Price Performance

Shares of NYSE ZTS opened at $144.15 on Friday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The business has a 50-day moving average of $148.73 and a 200-day moving average of $153.69. The stock has a market capitalization of $63.88 billion, a price-to-earnings ratio of 24.81, a PEG ratio of 2.32 and a beta of 0.90. Zoetis Inc. has a fifty-two week low of $139.34 and a fifty-two week high of $193.49.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.62 by $0.14. The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s payout ratio is presently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.